ACTU: ACTUATE THERAPEUTICS, INC. insider trading, 5% holders and institutional ownership

From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.

Insider trading

1 open-market buys totaling $50K and 0 sales totaling - in the last 180 days.

Insider buys

ScoreTickerCompanyInsiderRoleTrade dateValueHolding +Cluster
52ACTUACTUATE THERAPEUTICS, INC.Schmitt Daniel MCEO2026-10-28$50K47%

Activist and 5% holders

FiledWhatHolderStakeChangeFiling
2026-10-30New 13G stakeHexstone Capital LLC7.70%SEC

Institutional ownership (Q2 2026)

62 institutions reported holding $20.67M of ACTUATE THERAPEUTICS, INC. on Form 13F (61 the quarter before). 15 opened a new position and 15 sold out. Shares held by institutions: -2%.

Largest holdersSharesValue
BIOS Capital Management, LP10,049,996$15.38M
Voss Capital, LP1,725,000$2.64M
VANGUARD CAPITAL MANAGEMENT LLC393,433$602K
Palogic Value Management, L.P.200,000$306K
AQR CAPITAL MANAGEMENT LLC127,493$195K
GEODE CAPITAL MANAGEMENT, LLC112,554$172K
Texas Capital Bank Wealth Management Services Inc102,612$157K
MILLENNIUM MANAGEMENT LLC96,684$148K
BlackRock, Inc.90,035$138K
ABS Investment Management LLC73,186$112K

Get new insider and activist filings the morning after: daily alerts. Not investment advice.